|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
UTHR » Topics » This proxy should be executed and delivered if you (1) have not previously submitted a proxy or (2) previously submitted a proxy but wish to change your proxy with respect to Proposal 2. If you have previously submitted a proxy and do not wish to change yThis excerpt taken from the UTHR DEFA14A filed May 1, 2008. This proxy should be executed and delivered if you (1) have not previously submitted a proxy or (2) previously submitted a proxy but wish to change your proxy with respect to Proposal 2. If you have previously submitted a proxy and do not wish to change your vote, you do not need to re-submit a proxy. The undersigned holder of the common stock of United Therapeutics Corporation hereby names, constitutes and appoints Martine A. Rothblatt and Paul A. Mahon, and each of them, with full powers of substitution to act as true and lawful attorneys and proxies for the undersigned, and in the place and stead of the undersigned to attend the reconvened 2008 annual meeting of the shareholders of United Therapeutics Corporation to be held on Thursday, May 29, 2008, at 9:00 a.m. Eastern Time, and at any adjournment or postponement thereof, and to vote all the shares of common stock held of record in the name of the undersigned on March 7, 2008, with all the powers that the undersigned would possess if the undersigned were personally present. IMPORTANT NOTICE: Regarding the Internet Availability of Proxy Materials for United Therapeutics Corporation's 2008 Annual Meeting of Shareholders: United Therapeutics Corporation's Proxy Statement, Amendment No. 1 to Proxy Statement, 2007 Annual Report, Form 10-K and other proxy materials are available at: |
| |||||||